Published in Theor Biol Med Model on August 11, 2010
Nutritional management of a patient with obesity and pulmonary embolism: a case report. Nutr J (2016) 1.38
Prospective study of diet and venous thromboembolism in US women and men. Am J Epidemiol (2011) 0.84
A plant-based diet and stroke. J Geriatr Cardiol (2017) 0.75
Experimental Validation of Methods for Prophylaxis against Deep Venous Thrombosis: A Review and Proposal. Thrombosis (2012) 0.75
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
Intensive lifestyle changes for reversal of coronary heart disease. JAMA (1998) 6.53
Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA (2004) 6.38
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med (2003) 3.96
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med (2002) 3.96
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
Anticoagulation therapy for venous thromboembolism. MedGenMed (2004) 3.61
Virchow and his triad: a question of attribution. Br J Haematol (2008) 3.43
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation (2007) 3.20
Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.05
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med (2004) 2.60
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg (1988) 2.52
Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol (2004) 2.51
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev (2008) 2.37
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty (2008) 2.30
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost (2000) 2.15
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med (1997) 2.14
Deep vein thrombosis in acute spinal cord injury. Spinal Cord (2009) 2.06
The relation of nutrition to health; a statistical study of the effect of the war-time on arteriosclerosis, cardiosclerosis, tuberculosis and diabetes. Acta Med Scand Suppl (1950) 1.98
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95
Health effects of vegan diets. Am J Clin Nutr (2009) 1.84
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol (2004) 1.69
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med (2010) 1.68
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost (2005) 1.60
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am (2005) 1.59
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med (2000) 1.51
Does low meat consumption increase life expectancy in humans? Am J Clin Nutr (2003) 1.37
Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol (1989) 1.36
Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg (1991) 1.36
Value of anticoagulants in the treatment of pulmonary embolism: a discussion paper. J R Soc Med (1981) 1.22
Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev (2009) 1.17
Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation (2006) 1.14
von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol (2005) 1.13
Reduced or modified dietary fat for prevention of cardiovascular disease. Cochrane Database Syst Rev (2000) 1.13
The aetiology of deep venous thrombosis. QJM (2006) 1.12
Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost (1996) 1.09
Rheumatoid arthritis treated with vegetarian diets. Am J Clin Nutr (1999) 1.09
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost (2010) 1.08
Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr (1999) 1.07
The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med (2001) 1.06
Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res (1994) 1.06
Thromboembolism. Br Med Bull (2003) 1.05
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev (2009) 1.04
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost (2007) 1.02
Accuracy and epidemiological implications of the death certificate diagnosis of pulmonary embolism. J Chronic Dis (1984) 1.01
Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. Am J Cardiol (2010) 1.00
Prospective double-arm study of fibrinolysis in surgical patients. J Surg Res (1998) 1.00
Heparin prophylaxis in bedridden patients. Lancet (1996) 1.00
Vegetarian diets: what are the advantages? Forum Nutr (2005) 1.00
Treatment of deep-vein thrombosis--a random trial. Br J Surg (1968) 0.98
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet (2002) 0.97
Hemostatic factors and blood lipids in young Buddhist vegetarians and omnivores. Am J Clin Nutr (1993) 0.97
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
178 fatal cases of pulmonary embolism in a medical department. Acta Med Scand (1981) 0.97
Total cardiovascular risk profile of Taiwanese vegetarians. Eur J Clin Nutr (2007) 0.95
Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J (2009) 0.94
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension. J Pharmacol Exp Ther (2003) 0.93
Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial. J Bone Joint Surg Br (2009) 0.93
Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost (2005) 0.92
Lessons from dietary studies in Adventists and questions for the future. Am J Clin Nutr (2003) 0.92
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. J Thromb Haemost (2003) 0.92
Hemorrhagic complications of anticoagulant treatment. Chest (1992) 0.92
Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP). Thromb Haemost (2009) 0.91
The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters. Eur J Clin Nutr (1999) 0.91
Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. Circulation (2009) 0.90
A study of 605 fatal pulmonary embolisms and two successful embolectomies. Surg Gynecol Obstet (1967) 0.89
Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost (1999) 0.89
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. Arch Intern Med (2001) 0.88
Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. J Med Food (2006) 0.87
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism. Cochrane Database Syst Rev (2006) 0.86
Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape J Med (2008) 0.86
Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr (2001) 0.85
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost (2003) 0.85
Hematological, vitamin B 12, and folate studies on Seventh-day Adventist vegetarians. Am J Clin Nutr (1974) 0.85
Venous thromboembolism risk among hospitalized patients: magnitude of the risk is staggering. Am J Hematol (2007) 0.85
Risk stratification for venous thromboembolism in hospitalized patients in a developing country: a prospective study. J Thromb Thrombolysis (2008) 0.83
Relation of omega-3 Fatty Acid intake to other dietary factors known to reduce coronary heart disease risk. Am J Cardiol (2007) 0.83
Fish consumption and the risk of developing acute coronary syndromes: the CARDIO2000 study. Int J Cardiol (2005) 0.83
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. J Thromb Haemost (2007) 0.83
Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women. Eur J Nutr (2008) 0.82
Natural killer cells, vitamins, and other blood components of vegetarian and omnivorous men. Nutr Cancer (1989) 0.82
[Value of anticoagulant therapy in deep venous thrombosis in the lower limb in elderly, mobilized patients. A double-blind placebo controlled study with open therapeutic guidance]. Ugeskr Laeger (1988) 0.81
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag (2009) 0.80
A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. J Neurotrauma (2011) 2.98
Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol (2007) 2.44
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol (2003) 1.45
Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther (2007) 1.42
QTc interval prolongation associated with intravenous methadone. Pain (2003) 1.40
Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol (2011) 1.33
Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol (2010) 1.31
Teaching rational prescribing: a new clinical pharmacology curriculum for medical schools. Naunyn Schmiedebergs Arch Pharmacol (2002) 1.29
Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol (2003) 1.20
Large uterine leiomyomata and risk of cesarean delivery. Obstet Gynecol (2007) 1.14
The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc (2004) 1.11
Risks of induction of labour in women with a uterine scar from previous low transverse caesarean section. BJOG (2004) 1.06
Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol (2007) 1.03
Risk factors for cervical insufficiency after term delivery. Am J Obstet Gynecol (2006) 1.02
Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol (2008) 0.98
Legacy of Avicenna and evidence-based medicine. Int J Cardiol (2010) 0.97
Intraventricular hemorrhage and periventricular leukomalacia in preterm infants. Obstet Gynecol (2004) 0.97
Centers for education and research on therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United States. Clin Pharmacol Ther (2002) 0.96
Hospital length of stay--does 1% TBSA really equal 1 day? J Burn Care Res (2011) 0.95
Measures of placental growth in relation to birth weight and gestational age. Am J Epidemiol (2005) 0.94
A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol (2009) 0.94
Cervical length < or = 25 mm in low-risk women: a case control study of cerclage with rest vs rest alone. Am J Obstet Gynecol (2007) 0.93
The sub-peritoneal arterial plexus of Sir William Turner. Ann Anat (2010) 0.91
Urinary iodine percentile ranges in the United States. Clin Chim Acta (2003) 0.91
A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG (2004) 0.91
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics (2002) 0.91
Do thyroxine and thyroid-stimulating hormone levels reflect urinary iodine concentrations? Ther Drug Monit (2005) 0.90
The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial. Dis Colon Rectum (2010) 0.89
Wolf Motor Function Test for characterizing moderate to severe hemiparesis in stroke patients. Arch Phys Med Rehabil (2012) 0.89
Does air travel affect pregnancy outcome? Arch Gynecol Obstet (2003) 0.88
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol (2008) 0.88
Stochastic description of the ligand-receptor interaction of biologically active substances at extremely low doses. Cell Signal (2003) 0.86
Factors affecting survival in infants weighing 750 g or less. Eur J Obstet Gynecol Reprod Biol (2005) 0.84
Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Arch Gynecol Obstet (2003) 0.84
Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenat Diagn (2002) 0.84
Prevalence of pediatric dyslipidemia: comparison of a population-based claims database to national surveys. Pharmacoepidemiol Drug Saf (2010) 0.83
Fetal hydronephrosis: natural history and risk factors for postnatal surgery. J Perinat Med (2014) 0.83
Antenatal predictors of neonatal outcome in fetal growth restriction with absent end-diastolic flow in the umbilical artery. Am J Obstet Gynecol (2005) 0.82
A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer (2005) 0.82
Nicotine induces a long QT phenotype in Kcnq1-deficient mouse hearts. J Pharmacol Exp Ther (2003) 0.82
Preterm twins: what threshold of birth weight discordance heralds major adverse neonatal outcome? Am J Obstet Gynecol (2004) 0.82
Is 'Virchow's triad' useful? Br J Haematol (2009) 0.80
Ghrelin agonist TZP-101/ulimorelin accelerates gastrointestinal recovery independently of opioid use and surgery type: covariate analysis of phase 2 data. World J Surg (2012) 0.80
Epidemiology of bloodstream infections in burn-injured patients: a review of the national burn repository. J Burn Care Res (2010) 0.80
Hypothesis: intracellular acidification contributes to infertility in varicocele. Fertil Steril (2008) 0.79
Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non-diabetic pregnant women. Arch Gynecol Obstet (2004) 0.79
Epidemiologic study of smell disturbance in 2 medical insurance claims populations. Arch Otolaryngol Head Neck Surg (2007) 0.79
Randomized trial of McRoberts versus lithotomy positioning to decrease the force that is applied to the fetus during delivery. Am J Obstet Gynecol (2004) 0.78
Piezoelectricity and prostate cancer: proposed interaction between electromagnetic field and prostatic crystalloids. Cell Biol Int (2008) 0.78
Nomograms of the axial transverse diameter of the fetal foramen magnum between 14 and 40 weeks' gestation. J Ultrasound Med (2008) 0.78
Role of transvaginal sonographic cervical length in predicting spontaneous preterm delivery in triplet pregnancies with therapeutic cerclage. J Reprod Med (2003) 0.78
Leonardo da Vinci's studies of the heart. Int J Cardiol (2012) 0.77
The role of the renin--angiotensin system in the pathogenesis of intracranial aneurysms. J Renin Angiotensin Aldosterone Syst (2011) 0.77
Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects. Am Heart J (2002) 0.77
Duration of labor and risk of cerebral white-matter damage in very preterm infants who are delivered with intrauterine infection. Am J Obstet Gynecol (2005) 0.77
Can the unenhanced phase be eliminated from dual-phase CT angiography for chest pain? Implications for diagnostic accuracy in acute aortic intramural hematoma. AJR Am J Roentgenol (2014) 0.77
Variability in rate of cervical dilation in nulliparous women at term. Birth (2011) 0.77
Prediction of duration of active labor in nulliparous women at term. Am J Perinatol (2007) 0.76
Morphometry of the basal plate superficial uteroplacental vasculature in normal midtrimester and at term. Pediatr Dev Pathol (2005) 0.76
Risk of third-trimester amniocentesis: a case-control study. Am J Perinatol (2006) 0.75
Onset of epilepsy at the time of menarche. Neurology (2003) 0.75
Response to the letter to the editor by Armistead-jehle and Lee on Harch et Al., "A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder". J Neurotrauma (2012) 0.75
Prognostic value of uterine artery Doppler velocimetry in growth-restricted fetuses delivered near term. Am J Obstet Gynecol (2002) 0.75
Further reflections on Virchow's triad. South Med J (2005) 0.75
Defining risk groups to yellow fever vaccine-associated viscerotropic disease in the absence of denominator data. Am J Trop Med Hyg (2014) 0.75
Changing trends in the epidemiology of pediatric lead exposure: interrelationship of blood lead and ZPP concentrations and a comparison to the US population. Ther Drug Monit (2003) 0.75
Venous thromboembolism prophylaxis in hospitalized medical patients. Ann Intern Med (2012) 0.75
Editorial: hypotheses about protein folding--the proteomic code and wonderfolds. Theor Biol Med Model (2009) 0.75
Experimental Validation of Methods for Prophylaxis against Deep Venous Thrombosis: A Review and Proposal. Thrombosis (2012) 0.75
Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage. Am J Obstet Gynecol (2005) 0.75
Starting a diabetes self-management program in a free clinic. Diabetes Educ (2007) 0.75
Therapeutic cerclage may be more efficacious in women who develop cervical insufficiency after a term delivery. Am J Obstet Gynecol (2008) 0.75
Nomograms of the fetal neck circumference and area throughout gestation. J Ultrasound Med (2007) 0.75
Variability in pathologists' detection of placental meconium uptake. Am J Perinatol (2008) 0.75
Fetal growth after preterm premature rupture of membranes: is it related to amniotic fluid volume? J Matern Fetal Neonatal Med (2007) 0.75
Cranioplasty in medieval Persia and the potential spread of this knowledge to Europe. Childs Nerv Syst (2012) 0.75
Rabi Rashidi (Rashidi Quarters): a late thirteen to early fourteenth century Middle Eastern Medical School. Childs Nerv Syst (2012) 0.75
Directions in biomedical research: a plea for ideological pluralism. Med Hypotheses (2003) 0.75
Thyroid cancer 15 years after Chernobyl. Lancet (2002) 0.75
Effect of epidural anaesthesia on clinician-applied force during vaginal delivery. Am J Obstet Gynecol (2004) 0.75
Caveats for the use of humerus length in the prediction of fetal Down syndrome. Fetal Diagn Ther (2003) 0.75
Doppler predictors of adverse neonatal outcome in the growth restricted fetus at 34 weeks' gestation or beyond. Am J Obstet Gynecol (2003) 0.75
Lecithin/sphingomyelin ratio and lamellar body count. What values predict the presence of phosphatidylglycerol? J Reprod Med (2003) 0.75
Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP). J Matern Fetal Neonatal Med (2005) 0.75
Effect of operative vaginal delivery on the outcome of permanent brachial plexus injury. J Reprod Med (2003) 0.75
Performance of cervicovaginal fetal fibronectin in a community hospital setting. Arch Gynecol Obstet (2006) 0.75